GreenRoc Accelerates their World Class Project to Production as Early as 2028. Watch the full video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPureTech Share News (PRTC)

Share Price Information for PureTech (PRTC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 232.00
Bid: 231.00
Ask: 232.50
Change: 0.50 (0.22%)
Spread: 1.50 (0.649%)
Open: 238.50
High: 238.50
Low: 230.00
Prev. Close: 231.50
PRTC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Peel Hunt picks 'doublers' for the next 2-3 years

Tue, 18th Dec 2018 11:09

(Sharecast News) - Peel Hunt has named 29 companies it believes will double in value in the next two to three years, including JD Sports, GoCompare and CMC Markets.In "Stock Ideas for 2019: Doublers", published on Tuesday, Peel Hunt conceded it was difficult to predict how Brexit will affect markets, and noted that the FTSE All Share was on track to record its worst annual performance this year since 2008.But it added: "There are always some stocks that are dancing to their own particular tune which could deliver some healthy returns."Peel Hunt has given spread betting firm CMC Markets, which has seen profitability hit by tighter regulations and lower volatility, a price target of 200p."We are confident CMC will ultimately benefit from the impending market consolidation, expansion of the ANZ deal and return of market volatility," it argued. "Relatively small moves should result in significant operating leverage." A target price of 200p is double the last closing price of 100p.It called GoCompare, the price comparison website, a "great stock to help savings", arguing: "The share price has halved since the summer as the market has become unsettled at the near-term revenue trend and the launch of the innovative Saving as a Service product Weflip. "This ignores the profit protection achieved by the improvement in marketing margin and the strong operating cash generation." The price target is 140p, against Monday's close of 69p.Despite the wider retail sector's bumpy performance, JD Sports is one of Peel Hunt's preferred stocks. "It ticks all the boxes: it is growing strongly and winning share in its core market and that is true both online and in store." Peel Hunt also pointed to an "aggressive" overseas expansion."JD has a strong record of delivering and bettering expectations and despite the conditions in the UK, we think that forecasts are at worse underpinned." It added that the current multiple of 11 x PE was "way too low" and the target price is 550p not quite double the latest close.Another retailer to get the nod was Joules. "Against the background of retail turmoil and profit warnings, Joules recently reported first-half group revenue growth of 17.6% with profits tracking slightly ahead of expectations." Peel Hunt is targeting a share price of 400p, against Monday's close of 210p.Clinical stage biopharmaceutical company Motif Bio could see its share price surge early next year, argued Peel Hunt, with the US Food and Drug Administration due to give possible approval to Motif's antibiotic iclaprim on 13 February. Currently trading at 26p, Peel Hunt is targeting a price of 95p.Another healthcare company is PureTech Health, which Peel Hunt argued was "very undervalued" despite being well capitalised. The shares currently trade at 178p but Peel Hunt is looking for 313p.At Ten Entertainment, owner of bowling allies, Peel Hunt is forecasting earnings will rise by more than 50% over the next three years - although it conceded there was an "upside risk to expansion, like-for-like sales and margin forecasts".Peel Hunt said of The AA: "While there are a number of routes that may lead to the share price doubling, the common feature is the delivery of current consensus expectations."Early progress has been encouraging and further reassurance at the pre-close will be a key catalyst."Nanoco was a tech pick, as its new facility to make cadmium-free quantum dots and nanomaterials for its large US customer should be completed by the end of 2018, with volume production expected in the first half of 2019."This should be transformative for the company given the rapid growth in the sensor market," said Peel Hunt's analysts, with industry forecasts is for the 3D imaging & sensing market to increase from $2bn in 2017 to close to $10bn in 2020 and over $18bn by 2023, as Gartner calculated that around 40% of smartphones will have 3D sensors by 2021. The target price is 67p.Other companies highlighted by Peel Hunt included Eland Oil and Gas, Kaz Minerals, Manx Telecom, Polar Capital and Renold.
More News
13 May 2019 12:44

PureTech Health's Vedanta Biosciences Series C Raises USD45.5 Million

LONDON (Alliance News) - PureTech Health PLC said Monday its affiliate Vedanta Biosciences has extended its series C financing round by USD18.5 million.The extension takes the total amount

Read more
7 May 2019 11:57

PureTech's Vedanta Biosciences Microbiome Patent Upheld In Europe

LONDON (Alliance News) - PureTech Health PLC said Tuesday affiliate Vedanta Biosciences has had its "foundational" patent upheld by the European Patent Office.PureTech Health, for

Read more
26 Apr 2019 15:00

CORRECT (Apr 24): PureTech Health Loss Narrows; Affiliates Set To Earn

(Correcting movement of loss in headline.)LONDON (Alliance News) - Biotechnology company PureTech Health PLC on Wednesday reported a slightly narrower annual loss despite a sharp rise in in

Read more
24 Apr 2019 12:19

PureTech Health Loss Widens; Expects Six Affiliates To Begin Earning

LONDON (Alliance News) - Biotechnology company PureTech Health PLC on Wednesday reported a slightly narrower annual loss despite a sharp rise in revenue.In 2018, the US-based company, which

Read more
24 Apr 2019 09:17

PureTech narrows losses in 'most ambitious year yet'

(Sharecast News) - Biopharmaceutical company PureTech Health grew revenues and narrowed losses in its "most ambitious year yet".

Read more
17 Apr 2019 16:06

UK Earnings, Trading Statements Calendar - Next 7 Days

Thursday 18 April UnileverQ1 ResultsPZ CussonsTrading SolutionsTrading 19 events

Read more
17 Apr 2019 12:28

PureTech And Boehringer Team To Develop Immuno-Oncology Candidates

LONDON (Alliance News) - PureTech Health PLC on Wednesday said it has entered into a research collaboration with Boehringer Ingelheim to develop novel product candidates.Under terms of the

Read more
15 Apr 2019 10:40

WINNERS & LOSERS SUMMARY: IWG Up On GBP320 Million Japanese Unit Sale

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Monday.----------FTSE 100 - up 0.8%. The advertising and marketing firm a

Read more
11 Apr 2019 13:04

PureTech Health Affiliate Sonde Secures USD16 Million Of Funding

LONDON (Alliance News) - Biopharmaceutical firm PureTech Health PLC on Thursday said its Sonde Health affiliate has completed a USD16 million series A funding round.PureTech founded Sonde,

Read more
1 Apr 2019 14:40

PureTech Health Affiliate Karuna Completes USD80 Million Funding Round

LONDON (Alliance News) - Biopharmaceutical firm PureTech Health PLC said on Monday its affiliate Karuna Therapeutics Inc has raised USD12 million as an extension of its Series B financing first in

Read more
25 Mar 2019 18:09

PureTech Health Affiliate Reports Positive Results On Two Products

LONDON (Alliance News) - Biopharmaceutical firm PureTech Health PLC on Monday said that its affiliate Gelesis reported positive tests results on two products, Gel-B (GS300) and presented data that

Read more
18 Mar 2019 12:04

PureTech's Karuna Raises USD68 Million To Support Development Of KarXT (ALLISS)

LONDON (Alliance News) - PureTech Health PLC on Monday said its subsidiary Karuna Therapeutics Inc has completed a USD68 million series B refinancing round to advance the development of company of

Read more
14 Feb 2019 12:40

PureTech Health Partner Vor BioPharma Raises USD42 Million

LONDON (Alliance News) - PureTech Health PLC said on Thursday that affiliate Vor BioPharma has raised USD42 million to press ahead with a leukaemia treatment.Vor's funding round was led

Read more
14 Feb 2019 12:28

PureTech Health investment Vor Biopharma raises $42m in funding round

(Sharecast News) - Advanced biopharmaceutical company PureTech Health noted on Thursday that its affiliate, Vor Biopharma, had raised $42m in a Series A financing round.

Read more
28 Jan 2019 09:18

PureTech Health Affiliate Teams With Purdue Pharma To Improve ALV-107

LONDON (Alliance News) - PureTech Health PLC on Monday said its subsidiary Alivio Therapeutic Inc partnered with Purdue Pharma LP to advance candidate ALV-107 through clinical is Alivio's for

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.